Long-term safety of dupilumab in patients with moderate-to-severe asthma who completed the liberty asthma traverse continuation study

被引：0
|
作者：
Maspero, J. [1 ]
Peters, A. [2 ]
Chapman, K. [3 ]
Domingo, C. [4 ]
Stewart, J. [5 ]
Hardin, M. [6 ]
Maroni, J. [7 ]
Tawo, K. [8 ]
Khokhar, F. A. [7 ]
Mortenson, E. [7 ]
Laws, E. [8 ]
Amr, R. [7 ]
Jacob-Nara, J. A. [8 ]
Deniz, Y. [7 ]
Rowe, P. J. [8 ]
机构：
[1] Fdn Cidea, Buenos Aires, DF, Argentina
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Univ Toronto, Toronto, ON, Canada
[4] Autonomous Univ Barcelona, Corporacio Sanitaria Parc Tauli Sabadell, Barcelona, Spain
[5] Sanofi, Montreal, PQ, Canada
[6] Sanofi, Cambridge, MA USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Bridgewater, MA USA
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000186
引用
收藏
页码：188 / 189
页数：2
相关论文
共 50 条
  • [1] Long-term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: The Liberty Asthma Traverse Continuation Study
    Maspero, J. F.
    Peters, A.
    Chapman, K. R.
    Domingo, C.
    Stewart, J.
    Hardin, M.
    Maroni, J.
    Tawo, K.
    Khokhar, F. A.
    Mortensen, E.
    Laws, E.
    Radwan, A.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study
    Maspero, Jorge F.
    Peters, Anju T.
    Chapman, Kenneth R.
    Domingo, Christian
    Stewart, John
    Hardin, Megan
    Maroni, Jaman
    Tawo, Kelsey
    Khokhar, Faisal A.
    Mortensen, Eric
    Laws, Elizabeth
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (04): : 991 - 997.e6
  • [3] Long-term efficacy of dupilumab in patients with moderate-to-severe type 2 inflammation by age of asthma onset: LIBERTY ASTHMA TRAVERSE study
    Busse, William W.
    Kraft, Monica
    Domingo, Christian
    de Mir, Ines
    Maselli, Diego
    Xia, Changming
    Pandit-Abid, Nami
    Soler, Xavier
    Jacob-Nara, Juby A.
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    RESPIROLOGY, 2023, 28 : 11 - 12
  • [4] Long-Term Dupilumab Treatment in Moderate-to-Severe Asthma with Type 2 Inflammation: Open Label LIBERTY ASTHMA TRAVERSE Study
    Wechsler, M.
    Pavord, I. D.
    Papi, A.
    Chapman, K. R.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Ruddy, M. K.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [5] LONG-TERM EFFICACY OF DUPILUMAB: 3-YEAR DATA OF QUEST PATIENTS WITH MODERATE-TO-SEVERE ASTHMA ENROLLED IN LIBERTY ASTHMA TRAVERSE
    Pavord, I. D.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Domingo, C.
    Wechsler, M. E.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Mannent, L.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M.
    THORAX, 2021, 76 : A53 - A54
  • [6] Impact of Early Transient Increase in Eosinophil Count on the Long-term Efficacy of Dupilumab in Patients With Moderate-to-Severe Asthma: Liberty Asthma Traverse
    Lugogo, N. L.
    Pavord, I. D.
    Castro, M.
    Papi, A.
    Bourdin, A.
    Wechsler, M. E.
    Cote, A.
    Xia, C.
    Soliman, M.
    Pandit-Abid, N.
    Jacob-Nara, J. A.
    Sacks, H. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [7] Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
    Wechsler, Michael E.
    Ford, Linda B.
    Maspero, Jorge F.
    Pavord, Ian D.
    Papi, Alberto
    Bourdin, Arnaud
    Watz, Henrik
    Castro, Mario
    Nenasheva, Natalia M.
    Tohda, Yuji
    Langton, David
    Cardona, Guido
    Domingo, Christian
    Park, Hae Sim
    Chapman, Kenneth R.
    Mao, Xuezhou
    Zhang, Yi
    Khan, Asif H.
    Deniz, Yamo
    Rowe, Paul J.
    Kapoor, Upender
    Khokhar, Faisal A.
    Mannent, Leda P.
    Ruddy, Marcella
    Laws, Elizabeth
    Amin, Nikhil
    Hardin, Megan
    LANCET RESPIRATORY MEDICINE, 2022, 10 (01): : 11 - 25
  • [8] Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE
    Wechsler, Michael E.
    Ford, Linda B.
    Maspero, Jorge F.
    Pavord, Ian D.
    Tohda, Yuji
    Langton, David
    Domingo, Christian
    Papi, Alberto
    Bourdin, Arnaud
    Watz, Henrik
    Park, Hae Sim
    Chapman, Kenneth R.
    Mao, Xuezhou
    Ortiz, Benjamin
    Djandji, Michel
    Kapoor, Upender
    Khokhar, Faisal A.
    Mannent, Leda P.
    Ruddy, Marcella
    Laws, Elizabeth
    Amin, Nikhil
    Hardin, Megan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Noh, Hayeon
    Msihid, Jerome
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2024, 16 (04) : 372 - 386
  • [10] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Pavord, Id
    Wechsler, Me
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Kapoor, U.
    Khokhar, Fa
    Mannent, Lp
    Ruddy, M.
    Laws, E.
    Amin, N.
    Hardin, M.
    THORAX, 2021, 76 : A81 - A82
12345